DCF — TRISTAR STONECREST MEDICAL CENTER
Enterprise Value: $121.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$121.1M
Enterprise Value
$30.8M
PV of Cash Flows
$90.3M
PV of Terminal Value
$145.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $195.7M | $16.6M | 9.0% | $5.4M | $4.9M |
| Year 2 | $201.6M | $19.1M | 10.0% | $7.1M | $5.9M |
| Year 3 | $207.6M | $21.8M | 11.0% | $8.9M | $6.7M |
| Year 4 | $213.8M | $23.5M | 11.0% | $9.9M | $6.8M |
| Year 5 | $220.3M | $24.8M | 11.0% | $10.6M | $6.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $121.1M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$190.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000042105036
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5